As the global economy recovers in 2021 and the supply of the industrial chain improves, the Latent TB Detection market will undergo major changes. According to the latest research, the market size of the Latent TB Detection industry in 2021 will increase by USD million compared to 2020, with a growth rate of %.
The global Latent TB Detection industry report provides top-notch qualitative and quantitative information including: Market size (2017-2021 value and 2022 forecast). The report also contains descriptions of key players, including key financial indicators and market competitive pressure analysis.
The report also assesses key opportunities in the market and outlines the factors that are and will drive the growth of the industry. Taking into account previous growth patterns, growth drivers, and current and future trends, we also forecast the overall growth of the global Latent TB Detection market during the next few years. The global Latent TB Detection market size will reach USD million in 2028, growing at a CAGR of % during the analysis period.
Highlights-Regions
The Latent TB Detection market can be split based on product types, major applications, and important regions as follows:
North America
Europe
Asia Pacific
Latin America
Middle East & Africa
Highlights-Players
Major Players in Latent TB Detection market are:
QIAGEN
BioMeriux S.A.
F. Hoffmann La-Roche Ltd.
BD
ARKRAY, Inc.
Abbott
Serum Institute of India Pvt. Ltd
Oxford Immunotec Ltd
Lionex GmbH
Highlights-Types
Most important types of Latent TB Detection products covered in this report are:
Tuberculin Skin Test (TST)
Interferon Gamma Released Assay (IGRA)
Application listHighlights-Application
Most widely Application of Latent TB Detection market covered in this report are:
Hospitals
Diagnostic Centers
Laboratories
Others